Stephens Inc Neogenomics Inc Transaction History

Stephens Inc

$6.84 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$11.67 - $20.73 $875 - $1,554	-75 Reduced 0.72%	10,358 $167,000
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $5,467 - $8,032	-450 Reduced 4.13%	10,433 $128,000
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $352 - $495	25 Added 0.23%	10,883 $174,000
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $8,181 - $17,505	-900 Reduced 7.65%	10,858 $189,000
Q4 2022 Jan 25, 2023	BUY	$6.45 - $12.07 $483 - $905	75 Added 0.64%	11,758 $109,000
Q3 2022 Nov 02, 2022	SELL	$7.86 - $12.91 $23,580 - $38,730	-3,000 Reduced 20.43%	11,683 $101,000
Q2 2022 Aug 03, 2022	SELL	$7.06 - $13.97 $15,955 - $31,572	-2,260 Reduced 13.34%	14,683 $120,000
Q1 2022 May 04, 2022	SELL	$12.15 - $35.28 $54,711 - $158,865	-4,503 Reduced 21.0%	16,943 $206,000
Q4 2021 Mar 07, 2022	BUY	$30.49 - $48.49 $144,278 - $229,454	4,732 Added 28.31%	21,446 $732,000
Q3 2021 Oct 27, 2021	SELL	$41.66 - $52.52 $499 - $630	-12 Reduced 0.07%	16,714 $806,000
Q2 2021 Aug 12, 2021	BUY	$36.62 - $51.69 $29,369 - $41,455	802 Added 5.04%	16,726 $756,000
Q1 2021 May 14, 2021	BUY	$41.56 - $59.88 $41,560 - $59,880	1,000 Added 6.7%	15,924 $768,000
Q4 2020 Feb 10, 2021	SELL	$36.08 - $56.47 $83,344 - $130,445	-2,310 Reduced 13.4%	14,924 $804,000
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $34,291 - $41,734	-1,031 Reduced 5.64%	17,234 $636,000
Q2 2020 Aug 24, 2020	SELL	$24.21 - $31.02 $24,379 - $31,237	-1,007 Reduced 5.23%	18,265 $566,000
Q1 2020 May 14, 2020	SELL	$20.5 - $34.53 $9,799 - $16,505	-478 Reduced 2.42%	19,272 $532,000
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $132,833 - $209,059	-7,006 Reduced 26.18%	19,750 $578,000
Q3 2019 Oct 18, 2019	SELL	$19.12 - $26.24 $484,290 - $664,632	-25,329 Reduced 48.63%	26,756 $512,000
Q2 2019 Aug 01, 2019	SELL	$19.57 - $24.1 $507,841 - $625,395	-25,950 Reduced 33.25%	52,085 $1.14 Million
Q1 2019 May 03, 2019	BUY	$12.14 - $20.46 $594,410 - $1 Million	48,963 Added 168.42%	78,035 $1.6 Million
Q4 2018 Feb 11, 2019	SELL	$11.24 - $18.5 $319,586 - $526,010	-28,433 Reduced 49.44%	29,072 $367,000
Q3 2018 Nov 14, 2018	BUY	$12.5 - $15.38 $718,812 - $884,426	57,505 New	57,505 $883,000

Others Institutions Holding NEO

# of Institutions

294

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$287 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$205 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$100 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$96.2 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$95.3 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.83B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account